Dan Levitan

Dan Levitan has over 30 years of collective experience in venture capital and investing, specializing in leading consumer and retail businesses. Eager to help innovative companies realize their full potential, Dan launched Maveron in 1998 with Howard Schultz, former CEO of Starbucks Coffee Company. In his 23-year career at Maveron, Dan has led many successful exits, including zulily (NASDAQ: ZU), Potbelly (NASDAQ: PBPB), Trupanion (NYSE: TRUP), Capella Education Company (NASDAQ: CPLA), eBay (NASDAQ: EBAY), and Shutterfly (NASDAQ: SFLY). He currently serves on the Board of Directors for Allbirds, Daring Foods, Domain Money, Engageli, Otis, Pacaso, Trupanion, and Two Chairs. Dan currently serves as a member of the Boards of Trustees of Seattle Children’s Healthcare System and Seattle Children’s Hospital and he also serves on the Investment Advisory Committee for Seattle Children’s which oversees over $2B in AUM. Dan is also a board member of The Rock Center for Entrepreneurship at Harvard Business School where he acts as a judge at the annual New Venture Competition. Dan is also chair of Brothers for Life, a charity that helps wounded Israeli combat soldiers. Dan has been recognized by Forbes on its Midas List as one of the industry’s top technology investors. Dan has also been named NASDAQ private company director of the year. Dan graduated from Horace Mann School, received a BA magna cum laude from Duke University, and an MBA from Harvard Business School.